ArticleFrontiers in pharmacology2022

Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data.

Ha Young Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.